FUSO, ANDREA
 Distribuzione geografica
Continente #
NA - Nord America 3421
EU - Europa 947
AS - Asia 305
SA - Sud America 20
AF - Africa 9
OC - Oceania 2
Totale 4704
Nazione #
US - Stati Uniti d'America 3392
IT - Italia 391
SE - Svezia 273
IN - India 186
CN - Cina 113
UA - Ucraina 73
FI - Finlandia 72
DE - Germania 51
CA - Canada 28
RO - Romania 20
FR - Francia 19
AR - Argentina 18
GB - Regno Unito 13
AT - Austria 8
TG - Togo 6
BE - Belgio 5
IE - Irlanda 5
NL - Olanda 4
PT - Portogallo 3
ZA - Sudafrica 3
AL - Albania 2
GR - Grecia 2
IR - Iran 2
SA - Arabia Saudita 2
AU - Australia 1
BG - Bulgaria 1
BR - Brasile 1
BY - Bielorussia 1
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
IL - Israele 1
KR - Corea 1
MX - Messico 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
Totale 4704
Città #
Fairfield 626
Chandler 304
Seattle 260
Woodbridge 253
Ashburn 243
Houston 210
Wilmington 195
Cambridge 194
Rome 151
Ann Arbor 138
Princeton 110
San Paolo di Civitate 92
Plano 89
Beijing 76
Boston 61
Lawrence 57
Dearborn 53
Fremont 51
Millbury 37
San Diego 32
Andover 28
Bremen 24
Des Moines 24
Jacksonville 24
Norwalk 22
Federal 18
San Mateo 15
Falls Church 13
Ottawa 13
Boardman 11
Toronto 10
Grafing 9
Ferrara 7
Phoenix 7
Lomé 6
Nanjing 6
Valenza 6
Vienna 6
Bagneux 5
Dublin 5
Hefei 5
Milan 5
Duncan 4
Kunming 4
Leawood 4
New York 4
Padova 4
Perugia 4
Redmond 4
Sacramento 4
Surat 4
Ahmedabad 3
Brussels 3
Cachan 3
Catanzaro 3
Esslingen 3
Gignese 3
Helsinki 3
Laurel 3
Lisbon 3
Montréal 3
Mumbai 3
Napoli 3
Redwood City 3
San Francisco 3
Shenyang 3
Ancaster 2
Bolzano Vicentino 2
Buffalo 2
Chengdu 2
Edinburgh 2
Innsbruck 2
Langgöns 2
Nanchang 2
Philadelphia 2
Pomezia 2
Provo 2
Segrate 2
Silverton 2
Southend 2
Timisoara 2
Trieste 2
Venice 2
Assèmini 1
Auckland 1
Bologna 1
Bonn 1
Carrara 1
Centrale 1
Chongqing 1
Cogliate 1
Groningen 1
Guangzhou 1
Gustavo Adolfo Madero 1
Hadera 1
Hebei 1
Hyderabad 1
Indiana 1
Jackson 1
Jiaxing 1
Totale 3633
Nome #
Interleukin-18 modulation in autism spectrum disorders 108
Bioenergetic impairment in animal and cellular models of Alzheimer's disease: PARP-1 inhibition rescues metabolic dysfunctions 97
Methyl-CpG binding protein 2 functional alterations provide vulnerability to develop behavioral and molecular features of post-traumatic stress disorder in male mice 92
Environment, epigenetics and neurodegeneration: Focus on nutrition in Alzheimer's disease 91
null 88
Disclosing bias in bisulfite assay: MethPrimers underestimate high DNA methylation. 83
Cholinergic hypofunction in MeCP2-308 mice: Beneficial neurobehavioural effects of neonatal choline supplementation 81
Involvement of sperm acetylated histones and the nuclear isoform of Glutathione peroxidase 4 in fertilization 81
Alpha-lipoic acid downregulates IL-1β and IL-6 by DNA hypermethylation in SK-N-BE neuroblastoma cells 81
S-adenosylmethionine and superoxide dismutase 1 synergistically counteract Alzheimer's disease features progression in tgCRND8 mice 80
The complex interplay between DNA methylation and miRNAs in gene expression regulation 80
A reassessment of semiquantitative analytical procedures for DNA methylation: Comparison of bisulfite- and HpaII polymerase-chain-reaction-based methods 80
Sexually dimorphic expression of reelin in the brain of a mouse model of Alzheimer disease 78
DNA methylation profiles of selected pro-inflammatory cytokines in Alzheimer disease 78
GSK3β 5’-flanking DNA methylation and expression in Alzheimer’s disease patients 77
Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectives. 73
Cpg and non-Cpg presenilin1 methylation pattern in course of neurodevelopment and neurodegeneration is associated with gene expression in human and murine brain 73
S-adenosylmethionine and Superoxide-dismutase are effective in amyloidosis reduction in TgCRND8 mice. 72
Neonatal exposure to low dose corticosterone persistently modulates hippocampal mineralocorticoid receptor expression and improves locomotor/exploratory behaviour in a mouse model of Rett syndrome 72
Sertoli cells initiate testicular innate immune responses through TLR activation 71
S-adenosylmethionine inhibits ubiquitin-proteasome system in vitro and on rat vascular smooth muscle cells 71
S-adenosylmethionine/homocysteine cycle alterations modify DNA methylation status with consequent deregulation of PS1 and BACE and beta-amyloid production 68
Distribution of GFRA1-expressing spermatogonia in adult mouse testis 67
Gene silencing through methylation: an epigenetic intervention on Alzheimer Disease 65
S-adenosylmethionine reduces the progress of the Alzheimer-like features induced by B-vitamin deficiency in mice 64
Changes in Presenilin 1 gene methylation pattern in diet-induced B vitamin deficiency 63
Analytical performance of COVID-19 detection methods (RT-PCR): scientific and societal concerns 63
Chromatin-Modifying Agents Increase Transcription of CYP46A1, a Key Player in Brain Cholesterol Elimination 62
Identification of Spermatogonial Stem Cell Subsets by Morphological Analysis and Prospective Isolation 60
Role of S-adenosylmethionine in the modulation of oxidative stress-related neurodegeneration 60
Pharmacodynamics and pharmacokinetics of inositol(s) in health and disease 60
CpG and non-CpG methylation in the diet-epigenetics-neurodegeneration connection 60
Subcellular TSC22D4 localization in cerebellum granule neurons of the mouse depends on development and differentiation 59
RAGE and LRP1 modulation in TgCRND8 mice under condition of B vitamin deficiency. 59
Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease 58
PARP-1 inhibition decreases Beta-Amyloid-induced neurodegeneration: a cellular and animal model study 58
One-Carbon Metabolism Alteration Affects Brain Proteome Profile in a Mouse Model of Alzheimer's Disease 58
DNA methylase and demethylase activities are modulated by one-carbon metabolism in Alzheimer's disease models 56
Methylation of genes related to Alzheimer Disease in neuroblastoma cells 55
Stimulation of the serotonin receptor 7 restores brain histone H3 acetylation and MeCP2 corepressor protein levels in a female mouse model of Rett syndrome 55
PARP-1 Modulates Amyloid Beta Peptide-Induced Neuronal Damage 54
One-carbon metabolism and Alzheimer's disease: is it all a methylation matter? 53
Nicotine exposure during adolescence: cognitive performance and brain gene expression in adult heterozygous reeler mice 53
High density lipoproteins downregulate basic fibroblast growth factor production and release in minimally oxidated-LDL treated smooth muscle cells 53
Urokinase expression in course of benign and malignant mammary lesions: comparison between nodular and healthy tissues 53
PSEN1 promoter demethylation in hyperhomocysteinemic TgCRND8 mice is the culprit, not the consequence. 52
Pharmacological Stimulation of the Brain Serotonin Receptor 7 as a Novel Therapeutic Approach for Rett Syndrome. 52
S-Adenosylmethionine Prevents Oxidative Stress and Modulates Glutathione Metabolism in TgCRND8 Mice Fed a B-Vitamin Deficient Diet 52
null 51
Active demethylation of Non-CpG moieties in animals: A neglected research area 51
Nicotine Restores Wt-Like Levels of Reelin and GAD67 Gene Expression in Brain of Heterozygous Reeler Mice 48
B VITAMIN DEFICIENCY INVERSELY MODULATES RAGE AND LRP1 IN TGCRND8 MICE BRAIN 48
α-Lipoic acid vaginal administration contrasts inflammation and preterm delivery in rats 48
Proteomic analysis of TgCRND8 mice brain in condition of altered one-carbon metabolism. 48
Nutrition and dementia. 47
Evaluation of chemical and diastereoisomeric stability of S-adenosylmethionine in aqueous solution by capillary electrophoresis 47
γ-secretase is differentially modulated by alterations of Homocysteine cycle in neuroblastoma and glioblastoma cells. 42
B Vitamin Deficiency Promotes Tau Phosphorylation Through Regulation of GSK3 beta and PP2A 42
Nicotine inhibits apoptosis and stimulates proliferation in aortic smooth muscle cells through a functional nicotinic acetylcholine receptor. 42
miR-125a-5p impairs the metastatic potential in breast cancer via IP6K1 targeting 42
Sexually dimorphic expression of reelin in a mouse model of Alzheimer disease 41
Pharmacological stimulation of the serotonin receptor 7 substantially rescues behavioral, physiological and brain molecular alterations in a female mouse model of Rett syndrome 41
Ketone bodies promote amyloid-β1-40 clearance in a human in vitro blood-brain barrier model 41
The 'golden age' of DNA methylation in neurodegenerative diseases 40
B-Vitamin Deprivation Induces Hyperhomocysteinemia and Brain S-adenosylhomocsyteine, Depletes Brain S-adenosylmethionine, and Enhances PS1 and BACE Expression and Amyloid-β Deposition in Mice 39
Alterations in Methyl-CpG binding protein 2 functionality provide vulnerability to traumatic events 38
S-adenosylmethionine and derivatives thereof for the treatment and prevention of Alzheimer Disease 37
PARP activation modulates apoptosis events in cellular and animal models of Alzheimer disease 36
PARP-1 drives metabolic changes in Alzheimer's disease models 36
The inter-talk between mycobacterium tuberculosis and the epigenetic mechanisms 36
LP-211 persistently rescues neurobehavioral and physiological impairments via epigenetic modulation of brain histone acetylation in a mouse model of Rett syndrome 36
Altered levels of IL-18 in sera of autism patients as well as in reeler brain 34
Exacerbation of Alzheimer-like features induced by B-vitamin deficiency is reversed by exogenous S-adenosylmethionine supplementation in TgCRND8 mice. 32
Apoptotic events are modulated by poly(ADP-ribose)polymerase in cellular and animal models of Alzheimer disease 32
IS RAGE THE SO FAR UNIDENTIFIED TRAIT D'UNION BETWEEN VASCULAR RISK FACTORS AND ALZHEIMER'S DISEASE? 31
Natural products - alpha-lipoic acid and acetyl-L-carnitine - in the treatment of chemotherapy-induced peripheral neuropathy 31
null 31
Genotype, age and gender interaction in regulating BDNF expression in TgCRND8 Alzheimer's disease mice 31
Presenilin 1 gene silencing by S-adenosylmethionine: a treatment for Alzheimer disease? 30
Quantitative evaluation of CFTR pre-mRNA splicing dependent on the (TG)mTn poly-variant tract 30
Male mice carrying dysfunctional methyl-CpG binding protein 2 are vulnerable to traumas 29
Expressionof urokinase plasminogen activator (UPA) in malignant and benign breast tissue:analysis by quantitative RT-PCR assays 27
DNA methylation and CNS gene expression in AD models. 26
Methyl-CpG binding protein 2 (MeCP2) dysfunction provides vulnerability to traumatic events in male mice 26
GENE SILENCING BY S-ADENOSYLMETHIONINE IN MUSCLE DIFFERENTIATION 26
Aging and Disease: The Epigenetic Bridge 25
M36 EXPRESSION OF UROKINASE PLASMINOGEN ACTIVATOR(UPA)IN MALIGNANT E BINIGN BREAST TISSUE: ANALYSIS BY QUANTITATIVE RT-PCR ASSAYS 24
Efefct of one-carbon metabolism alteration on DNA methylation machinery in Alzheimer’s Disease models. . 24
null 23
The Dynamics of Myogenin Site-specific Demethylation is Strongly Correlated with its Expression and with Muscle Differentiation 23
Use of S-adenosylmethionine (SAM) and superoxide dismutase (SOD) for the preparation of medicaments for the treatment of Alzeimer's disease 22
Trauma-exposed methyl-CpG binding protein 2 mutant mice: a new animal model for post-traumatic stress disorder 21
Early demethylation of non-CpG, CpC-rich, elements in the myogenin 5 '-flanking region A priming effect on the spreading of active demethylation? 19
ROLE OF POLY(ADP-RIBOSE)POLYMERASE IN AMYLOID BETA TOXICITY AND ALZHEIMER DISEASE 18
Methylation Impairment and Alzheimer’s Disease. 17
Nutrition-Based Modulation of Poly-ADP-Ribosylation and its possible role in Alzheimer’s disease 17
DNA methylation in diagnostics: State of the art and perspectives 17
The effect of S-adenosylmethionine on CNS gene expression studied by cDNA microarrays analysis 17
Complex expression of BDNF and reelin in the developing and adult brain of TgCRND8 mice 11
Alpha-lipoic acid represses IL-1B and IL-6 through DNA methylation in ovarian cells 8
Totale 4958
Categoria #
all - tutte 7240
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 87
selected - selezionate 0
volume - volumi 0
Totale 7327


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/201825 0000 00 62 15002
2018/2019643 035313 166 1210 196220213
2019/20201297 182333748 132159 199141 139948350
2020/2021538 49641930 761 2548 64904338
2021/20221213 21659460 14038 28116 7476314187
2022/2023984 20825796154 105148 160 0000
Totale 4974